glp-1 drugs available in usa Swiss Re says could reduce US mortality by up to 6.4% US health insurance plan drops

Percentages are rounded up to one decimal place BID two times a day, BMI body mass index, BMOD intensive behavior modification, GLP-1RA glucagon-like peptide 1 receptor agonist, IBT intensive behavioral therapy, NR not reported, OAD oral antihyperglycemic drug, PT phentermine-topiramate, QD once-daily, TID three times per day a Based on patients achieving 5% weight loss during the run-in period b NB16: sustained-release naltrexone 16 mg per day plus sustained-release bupropion 360 mg per day combined in fixed-dose tablets

Hegeds ZI, Jakab ME, Gergely TG, Sayour NV, Kovcs A, Antal S, et al

Retrieved 12 March 2024

When a person loses weight, their metabolism naturally slows down

As a dual GIP/GLP-1 receptor agonist, it targets two hormonal pathways instead of one

The FDA has approved a total of 9 GLP-1RAs, with approved indications including type 2 diabetes and weight loss